Also known as Altace
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure. It is marketed as Prilace by Arrow Pharmaceuticals in Australia, Ramipro by Westfield Pharma in the Philippines, Tritace by Sanofi-Aventis in Italy and and United States and Altace by King Pharmaceuticals in the United States, Ramitens by PharmaSwiss, Ampril by Krka in Slovenia, Corpril by Cemelog-BRS in Hungary, Piramil and Prilinda by Hemofarm in Serbia, by Lek in Poland and by Novartis in Bangladesh, and in Canada as Altace (Sonfi) and Ramipril (Pharmascience).Source: Wikipedia
Estimated Total Cost: $16.95 for an average of 28 days supply
Patients are most commonly prescribed ramipril to treat coronary atherosclerosis, cardiomyopathy, ischemic heart disease, and endocarditis.